These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19333378)

  • 1. The phospholipid scramblases 1 and 4 are cellular receptors for the secretory leukocyte protease inhibitor and interact with CD4 at the plasma membrane.
    Py B; Basmaciogullari S; Bouchet J; Zarka M; Moura IC; Benhamou M; Monteiro RC; Hocini H; Madrid R; Benichou S
    PLoS One; 2009; 4(3):e5006. PubMed ID: 19333378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.
    McNeely TB; Dealy M; Dripps DJ; Orenstein JM; Eisenberg SP; Wahl SM
    J Clin Invest; 1995 Jul; 96(1):456-64. PubMed ID: 7615818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription.
    McNeely TB; Shugars DC; Rosendahl M; Tucker C; Eisenberg SP; Wahl SM
    Blood; 1997 Aug; 90(3):1141-9. PubMed ID: 9242546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I.
    Wahl SM; McNeely TB; Janoff EN; Shugars D; Worley P; Tucker C; Orenstein JM
    Oral Dis; 1997 May; 3 Suppl 1():S64-9. PubMed ID: 9456660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced secretory leukocyte protease inhibitor in human immunodeficiency virus type 1-infected patients.
    Baqui AA; Meiller TF; Falkler WA
    Clin Diagn Lab Immunol; 1999 Nov; 6(6):808-11. PubMed ID: 10548568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary secretory leukocyte protease inhibitor increases in HIV infection.
    Lin AL; Johnson DA; Stephan KT; Yeh CK
    J Oral Pathol Med; 2004 Aug; 33(7):410-6. PubMed ID: 15250833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel secretory leukocyte protease inhibitor-binding protein involved in membrane phospholipid movement.
    Tseng CC; Tseng CP
    FEBS Lett; 2000 Jun; 475(3):232-6. PubMed ID: 10869562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of HIV Replication in Monocyte-Derived Macrophages (MDM) by Host Antiviral Factors Secretory Leukocyte Protease Inhibitor and Serpin Family C Member 1 Induced by Steroid Hormones.
    Biswas S; Chen E; Gao Y; Lee S; Hewlett I; Devadas K
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretory leukocyte protease inhibitor inhibits expression of polymeric immunoglobulin receptor via the NF-κB signaling pathway.
    Mikami Y; Iwase T; Komiyama Y; Matsumoto N; Oki H; Komiyama K
    Mol Immunol; 2015 Oct; 67(2 Pt B):568-74. PubMed ID: 26239418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretory leukocyte protease inhibitor binds to Neisseria gonorrhoeae outer membrane opacity protein and is bactericidal.
    Cooper MD; Roberts MH; Barauskas OL; Jarvis GA
    Am J Reprod Immunol; 2012 Aug; 68(2):116-27. PubMed ID: 22537232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity.
    Jana NK; Gray LR; Shugars DC
    J Virol; 2005 May; 79(10):6432-40. PubMed ID: 15858026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory function of secretory leukocyte proteinase inhibitor (SLPI) in human saliva is HIV-1 specific and varies with virus tropism.
    Skott P; Lucht E; Ehnlund M; Björling E
    Oral Dis; 2002 May; 8(3):160-7. PubMed ID: 12108760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes simplex virus downregulates secretory leukocyte protease inhibitor: a novel immune evasion mechanism.
    Fakioglu E; Wilson SS; Mesquita PM; Hazrati E; Cheshenko N; Blaho JA; Herold BC
    J Virol; 2008 Oct; 82(19):9337-44. PubMed ID: 18667508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus type-1 (HIV-1) replication is unaffected by human secretory leukocyte protease inhibitor.
    Turpin JA; Schaeffer CA; Bu M; Graham L; Buckheit RW; Clanton D; Rice WG
    Antiviral Res; 1996 Mar; 29(2-3):269-77. PubMed ID: 8739605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of oral secretory leukocyte protease inhibitor in HIV-infected subjects with long-term use of antiretroviral therapy.
    Nittayananta W; Kemapunmanus M; Yangngam S; Talungchit S; Sriplung H
    J Oral Pathol Med; 2013 Mar; 42(3):208-15. PubMed ID: 23126266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous salivary inhibitors of human immunodeficiency virus.
    Shugars DC; Alexander AL; Fu K; Freel SA
    Arch Oral Biol; 1999 Jun; 44(6):445-53. PubMed ID: 10401522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression and clinical significance of secretory leukocyte proteinase inhibitor (SLPI) in mammary carcinoma using bioinformatics analysis.
    Xie W; Zhang H; Qin S; Zhang J; Fan X; Yin Y; Liang R; Long H; Yi W; Fu D; Ma C; Lv M; Yu F
    Gene; 2019 Dec; 720():144088. PubMed ID: 31476404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipid flip-flop and phospholipid scramblase 1 (PLSCR1) co-localize to uropod rafts in formylated Met-Leu-Phe-stimulated neutrophils.
    Frasch SC; Henson PM; Nagaosa K; Fessler MB; Borregaard N; Bratton DL
    J Biol Chem; 2004 Apr; 279(17):17625-33. PubMed ID: 14766753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretory leukocyte protease inhibitor binds to annexin II, a cofactor for macrophage HIV-1 infection.
    Ma G; Greenwell-Wild T; Lei K; Jin W; Swisher J; Hardegen N; Wild CT; Wahl SM
    J Exp Med; 2004 Nov; 200(10):1337-46. PubMed ID: 15545357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretory Leukocyte Protease Inhibitor (SLPI): Emerging Roles in CNS Trauma and Repair.
    Hannila SS
    Neuroscientist; 2015 Dec; 21(6):630-6. PubMed ID: 25118190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.